SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs agreement to acquire low-band spectrum for Starlink Mobile sparked a sharp selloff in T-Mobile and other wireless carriers as traders weighed the prospect of a new competitor. The community is divided between seeing a meaningful long-term threat and calling the reaction excessive because building a competitive network would take substantial time and investment.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

SpaceXs agreement to acquire low-band spectrum for Starlink Mobile has raised concerns about future competition for AT&T and weighed on telecom shares. Traders are divided between viewing the selloff as an overreactiongiven the years and infrastructure needed to build a rival networkand seeing the deal as a credible long-term threat; many are also buying the dip for AT&Ts dividend.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the following business segments: Consumer and Business. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizons sharp selloff follows SpaceXs agreement to acquire low-band spectrum for Starlink Mobile, fueling concern that it could eventually compete for wireless customers. Traders are divided between viewing the deal as a long-term threat and calling the reaction excessive given the infrastructure and time needed to build a competing network; some see the drop as a buying opportunity based on Verizons dividend and cash flows.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is drawing attention amid a steep, sustained share-price decline that investors say lacks a clear explanation, with frustration focused on managements limited communication. The debate centers on whether Auvelitys Alzheimers agitation launch is gaining traction: bulls cite rising prescriptions and possible data undercounting, while skeptics question whether uptake is accelerating enough to support growth and a path to profitability.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

Renewed strength in the Magnificent Seven and reports of fresh highs have put MAGS in focus, with traders saying mega-cap tech is leading the market while smaller stocks lag. Optimists see leadership continuing, while skeptics point to narrow breadth and uncertain returns on AI spending as risks.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is rallying to fresh highs amid strength in software stocks, with traders highlighting its breakout and momentum. Bulls point to AI-related observability demand, while skeptics warn that the valuation is stretched and the move could reverse.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas Nasdaq-100 reentry and a reported NIH effort to accelerate personalized cancer vaccines have fueled buying, alongside optimism about its partnered mRNA melanoma-vaccine program with Merck. Traders are divided over whether index-related demand and cancer-vaccine hopes justify the sharp run, with skeptics pointing to valuation and ongoing losses and warning of a pullback.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is drawing attention as traders position around its upcoming earnings report amid a busy semiconductor reporting cycle. Many expect AI-related chip demand to support the outlook, while others are cautious about a pullback or prefer to wait for the results.

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgos autonomous-lab push is drawing attention, including the Araceli imaging-system integration and lab access and protein-testing services for NSF X-Labs researchers. Bulls see potential in AI-driven biology infrastructure, while skeptics question whether the partnerships will translate into revenue amid cash-burn concerns and sharp share-price swings.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

A joint request to extend claim-construction briefing deadlines in Aurinias generic-voclosporin patent litigation has fueled speculation that settlements may be nearing, though none is confirmed. Traders welcomed the share-price rebound, while others expect it to fade and remain frustrated by continued delays and limited company updates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Strong Sell Stocks for September 23rd

BCSF, BBW and FSBW have been added to the Zacks Rank #5 (Strong Sell) List on September 23rd, 2026.

Bain Capital Specialty Finance, Inc. Announces June 30, 2026 Financial Results and Declares Third Quarter 2026 Dividend of $0.42 per Share

Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the Company, our or we) today announced financial results for the second quarter ended June 30, 2026, and that its Board of Directors (the Board) has declared a dividend of $0.42 per share for the third quarter of 2026. "BCSF delivered solid net...

Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Second Quarter Ended June 30, 2026

Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the Company, our or we) today announced it will report its financial results for the second quarter ended June 30, 2026 on Monday, August 10, 2026 after market close. Management will host a conference call on Tuesday, August 11, 2026 at 8:30 a.m...

Oversold Conditions For Bain Capital Specialty Finance (BCSF)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

Bain Capital Specialty (BCSF) Upgraded to Buy: What Does It Mean for the Stock?

Bain Capital Specialty (BCSF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Bain Capital Specialty Finance, Inc. Announces March 31, 2026 Financial Results and Declares Second Quarter 2026 Dividend of $0.42 per Share

Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the Company, our or we) today announced financial results for the first quarter ended March 31, 2026, and that its Board of Directors (the Board) has...

Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the First Quarter Ended March 31, 2026

Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the Company) today announced it will report its financial results for the first quarter ended March 31, 2026 on Monday, May 11, 2026 after market...

Bain Capital Specialty Finance (BCSF) Expected to Announce Earnings on Monday

Bain Capital Specialty Finance (NYSE:BCSF) will be releasing its Q1 2026 earnings after the market closes on Monday, May 4. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-4-bain-capital-specialty-finance-inc-stock...

JPMorgan Chase & Co. Has $932,000 Stock Holdings in Bain Capital Specialty Finance, Inc. $BCSF

JPMorgan Chase & Co. cut its holdings in Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) by 62.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm...

Bain Capital Specialty Finance, Inc. $BCSF Shares Bought by Muzinich & Co. Inc.

Muzinich & Co. Inc. raised its position in Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) by 21.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities...

Bain Capital Specialty Finance, Inc. is a closed-end, non-diversified management investment company, which engages in the business of capitalizing on opportunities within advisor’s senior direct lending strategy, which seeks to provide risk-adjusted returns and current income to its stockholders by investing primarily in middle-market companies. The company was founded on October 5, 2015 and is headquartered in Boston, MA.

Bain Capital Specialty Finance Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$10.62
Prev Close	$10.78
Open	$10.77
Dividend Yield	12.08%
50-Day Moving Average	$11.74
Beta	0.67
Avg. Volume	553,366.48
PE Ratio	10.78

52-Week High	$14.51
52-Week Low	$10.53
Market Capitalization	$699.28M
EPS (Annual)	$1.52
Price to Book	0.64
Revenue Per Employee	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

BCSF Fundamentals